|
Symbol Name ID |
Alox5ap
arachidonate 5-lipoxygenase activating protein MGI:107505 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Alox5aptm1Bhk/Alox5aptm1Bhk involves: 129P2/OlaHsd * 129S/SvEv |
abnormal thromboxane level | J:39229 |
| decreased acute inflammation | J:39229 | |
| decreased leukotriene level | J:39229 | |
| impaired neutrophil recruitment | J:39229 | |
| increased prostaglandin level | J:39229 | |
| Alox5aptm1Bhk/Alox5aptm1Bhk involves: 129P2/OlaHsd * C57BL/6 * DBA/2 |
decreased susceptibility to type I hypersensitivity reaction | J:39229 |
| Alox5aptm1Jdm/Alox5ap+ DBA/1LacJ-Alox5aptm1Jdm |
decreased leukotriene level | J:100736 |
| decreased susceptibility to induced arthritis | J:100736 | |
| normal immune system phenotype | J:100736 | |
| Alox5aptm1Jdm/Alox5aptm1Jdm DBA/1LacJ-Alox5aptm1Jdm |
abnormal leukotriene level | J:100736 |
| abnormal prostaglandin level | J:100736 | |
| decreased inflammatory response | J:100736 | |
| decreased susceptibility to induced arthritis | J:100736 | |
| normal immune system phenotype | J:100736 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 10/07/2025 MGI 6.24 |
|
|
|
||